During the past decade, Seibo International Catholic Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Seibo International Catholic Hospital" are "Psoriasis" (3 trials), "Palmoplantar Pustulosis" (1 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "Seibo International Catholic Hospital" in a lesser frequency.

Most popular intervention types in "Seibo International Catholic Hospital" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Apremilast" (2 trials), "Mirikizumab" (2 trials), "Placebo" (2 trials), "PF-06826647" (1 trials) and "PF-06826647 or Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seibo International Catholic Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Seibo International Catholic Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Seibo International Catholic Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Seibo International Catholic Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".